European Commission Approves First Tocilizumab Biosimilar
The biosimilar, commercially called Tyenne, is indicated to treat several autoimmune diseases as well as cytokine release syndrome and COVID-19.
Source: medscape.com
L Antagonist News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from L Antagonist. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In L Antagonist Today - Breaking & Trending Today
Anti-inflammatory Strategy in Acute Myocarditis — No Benefit
A short course of the interleukin-1 receptor antagonist, anakinra, appeared safe but did not reduce complications of acute myocarditis in the ARAMIS trial.
Source: medscape.com
MoonLake Immunotherapeutics Explores Sale: Sources
MoonLake Immunotherapeutics, a developer of an antibody-derived treatment for inflammatory skin conditions, is exploring a sale, according to people familiar with the matter.
Source: medscape.com
Registry Data 'Reassure' on RA Biologics' Heart Attack Risk
There is no difference in the risk of myocardial infarction with interleukin-6 (IL-6) vs anti-tumor necrosis factor (TNF) therapy for rheumatoid arthritis.
Source: medscape.com
Guselkumab and Golimumab: Better Together for Ulcerative Colitis
People with moderate-to-severe ulcerative colitis benefit from a combination of these monoclonal antibodies, compared with induction with either agent alone, according to a new phase 2a study.
Source: medscape.com